Skip to Content

    This producer of small heart pumps hasn’t missed a beat as the FDA approved Impella 2.5, a version of its flagship device for high-risk patients.

    Fortune Data StoreLooking for leads, investment insights, or competitive intelligence?Get Premium Access

    Company Information

    Location
    Danvers, MA
    Industry
    Medical Products & Equipment
    Sector
    Health Care
    Fortune 500 Rank-
    Fortune 500 Profile-
    Current Streak1
    Years on List1
    CEO
    Michael R. Minogue
    Websitehttp://www.abiomed.com

    Revenue, Net Income

    Revenue Past Four Quarters230
    Net Income Past Four Quarters114

    Growth Rates

    EPS 3 yr Annual Growth Rate65%
    Rev 3 yr Annual Growth Rate20%
    Total Return 3 yr Annual Rate42%
    Beat S&P 3 yr Total Return?
    yes

    Rank

    EPS Growth Rank34
    Revenue Growth Rank87
    Total Return Rank
    50